에 대한 최신 뉴스 3M (NYSE:MMM) 주식

3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.

Earnings

News

Previews

3M 실적 미리보기: 이 산업 거인의 실적이 기대치를 다시 넘을 수 있을까?

Large Cap

Macro Economic Events

Mid Cap

Sector ETFs

Eurozone

Commodities

Small Cap

Econ #s

Economics

Federal Reserve

Markets

Tech

ETFs

GOOGL

TSLA

기술기업들 수익 시즌은 거래 주간 동안 매그니피센트 세븐 회사들의 주가가 모두 하락함에 따라 투자자들의 실망으로 시작되었다. 알파벳(NASDAQ:GOOGL)은 예상보다 높은 매출과 이익을 발표했지만, 유튜브 광고 매출에 대한 분석가들의 목표를 달성하지 못해 구글의 모회사 주가가 올해 최악의 한 주가 되었다.

이번 주 시장 동향: 기술주가 수익률 하락, 강력한 미국 경제로 소형주는 계속 상승세

Pre-Market Outlook

Trading Ideas

CHTR

DECK

금요일 아침 (현지 시간 기준) 미국 주식 선물이 더 높게 거래되면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: 월스트리트는 브리스톨-마이어스 스퀴브(NYSE:BMY)가 개장 전 115억 5천만 달러의 매출과 주당 1.63달러의 분기 이익을 보고할 것으로 예상하고 있다. Benzinga Pro의 데이터에 따르면, 브리스톨-마이어스 스퀴브의 주가는 시간외 거래에서 0.4% 하락한 45.10달러를 기록했다.

금요일 주목해야 할 주식: 브리스톨-마이어스 스퀴브, 데커스 아웃도어 그리고 3종목

3M Co

Avenira Ltd

QUAD M SOLUTIONS INC by Quad M Solutions Inc.

Quad M Solutions Inc

MERMAID MARITIME PCL by Mermaid Maritime Public Company Ltd.

Mermaid Maritime PCL

MAMMOTH RESOURCES CORP by Mammoth Resources Corp.

Mammoth Resources Corp

MASS MEGAWATTS WIND PWR by Mass Megawatts Wind Power, Inc.

Mass Megawatts Wind Power Inc

3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $152.5, a high estimate of $184.00, and a low estimate of $100.00. This upward trend is evident, with the current average reflecting a 13.81% increase from the previous average price target of $134.00.
<img src="https://www.benzinga.com/files/images/story/2024/1731528072_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of 3M among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$184.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$100.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$160.00</td>
<td>$143.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Scott Davis</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$180.00</td>
<td>-</td>
</tr>
<tr>
<td>Brett Linzey</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Joe O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$140.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$125.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to 3M. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of 3M compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of 3M's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into 3M's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MMM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 3M analyst ratings.</a>
<h2>Unveiling the Story Behind 3M</h2>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>3M: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: 3M displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 0.38%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: 3M's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.8%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 32.06%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): 3M's ROA excels beyond industry benchmarks, reaching 3.26%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 2.97, 3M faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

3M Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)

Investors with a lot of money to spend have taken a bullish stance on 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MMM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 21 uncommon options trades for 3M.
This isn't normal.
The overall sentiment of these big-money traders is split between 61% bullish and 28%, bearish.
Out of all of the special options we uncovered, 19 are puts, for a total amount of $1,006,569, and 2 are calls, for a total amount of $59,550.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $95.0 and $165.0 for 3M, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of 3M stands at 521.75, with a total volume reaching 12,269.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in 3M, situated within the strike price corridor from $95.0 to $165.0, throughout the last 30 days.
<h3>3M 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731525363_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.7</td>
<td>$6.35</td>
<td>$6.7</td>
<td>$135.00</td>
<td>$75.7K</td>
<td align="right">912</td>
<td>1.0K</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.75</td>
<td>$6.5</td>
<td>$6.5</td>
<td>$135.00</td>
<td>$74.8K</td>
<td align="right">912</td>
<td>784</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.95</td>
<td>$6.6</td>
<td>$6.6</td>
<td>$135.00</td>
<td>$73.2K</td>
<td align="right">912</td>
<td>558</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.75</td>
<td>$6.55</td>
<td>$6.56</td>
<td>$135.00</td>
<td>$72.8K</td>
<td align="right">912</td>
<td>669</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.65</td>
<td>$6.35</td>
<td>$6.37</td>
<td>$135.00</td>
<td>$69.8K</td>
<td align="right">912</td>
<td>894</td>
</tr>
</tbody>
</table>

<h3>About 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Where Is 3M Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,363,139, the MMM's price is up by 0.74%, now at $131.32. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 69 days.</li>
</ul>
<h3>What The Experts Say On 3M</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $157.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a positive move, an analyst from UBS has upgraded their rating to Buy and adjusted the price target to $184. 
&#x2A; An analyst from B of A Securities persists with their Buy rating on 3M, maintaining a target price of $160. 
&#x2A; An analyst from RBC Capital persists with their Underperform rating on 3M, maintaining a target price of $100. 
&#x2A; An analyst from Melius Research has elevated its stance to Buy, setting a new price target at $180. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for 3M, targeting a price of $165. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for 3M with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on MMM Options

UBS analyst Damian Karas upgrades 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) from Neutral to Buy and raises the price target from $130 to $184.

Upgrades

Price Target

UBS Upgrades 3M to Buy, Raises Price Target to $184

WIIM

AAON

ALGT

ALTG

AREB

BECN

CSTE

CSWI

FAST

FERG

FTAI

GATX

HUBG

IIIN

JELD

KTOS

MATW

REZI

ROCK

RUSHA

RUSHB

SKYW

TFII

UFPI

WLFC

Shares of companies within the broader industrial sector are trading higher after Donald Trump won the 2024 presidential election.

3M shares are trading higher after JP Morgan maintained an Overweight rating on the stock and raised its price target from $160 to $165.

JP Morgan analyst Stephen Tusa maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Overweight and raises the price target from $160 to $165.

JP Morgan Maintains Overweight on 3M, Raises Price Target to $165

RBC Capital analyst Deane Dray maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Underperform and raises the price target from $99 to $100.

RBC Capital Maintains Underperform on 3M, Raises Price Target to $100

Analysts boosted the price target for 3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) following yesterday&#8217;s strong third-quarter results.
The company&#8217;s adjusted net sales totaled&nbsp;$6.068 billion, marginally above the consensus of $6.057 billion, and adjusted EPS of $1.98&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41453239/post-it-maker-3m-q3-earnings-sales-growth-slows-margins-expand-raises-annual-profit-outlook" rel="noreferrer noopener">exceeded the consensus of&nbsp;$1.90</a>.
3M revised FY24 adjusted EPS&nbsp;guidance&nbsp;to&nbsp;$7.20 – $7.30&nbsp;from&nbsp;$7.00 – $7.30&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">versus the&nbsp;consensus of $7.26</a>.
Related: <a target="_blank" href="https://www.benzinga.com//node/41453239" rel="noreferrer noopener">Post-It Maker 3M Q3 Earnings: Sales Growth Slows, Margins Expand, Raises Annual Profit Outlook</a>
BofA Securities analyst Andrew Obin raised the price target to $160 from $143 while <a target="_blank" href="https://www.benzinga.com/quote/MMM/analyst-ratings" rel="noreferrer noopener">maintaining a Buy rating.</a>
The analyst writes that 3M appears cautious about 2025, which he interprets as a reflection of limited macroeconomic visibility rather than an indication of the effectiveness of its internal growth initiatives.
The analyst notes that the company is hesitant to identify an inflection point in the cycle, aligning with the messages from other multi-industrial companies in his coverage that are exposed to short cycles.
Increased volumes during a cyclical recovery should significantly enhance 3M&#8217;s margins, adds the analyst.
Obin writes that 3M&#8217;s growth profile has become more cyclical relative to the PMI during economic slowdowns, likely due to fewer new product launches in recent years.
Reaccelerating organic growth throughout the cycle is a key focus for the CEO, but cyclical leverage is expected to be the primary driver of earnings growth in the coming quarters, adds the analyst.
The analyst maintains 2024 EPS at $7.30, which is at the high end of 3M&#8217;s guidance.
Apart from this, RBC Capital Markets analyst Deane Dray increased the price target to $100 from $99 and reiterated the Underperform rating.
The analyst writes that despite CEO Bill Brown's effective strategies for tackling 3M&#8217;s operational weaknesses, the company is still in the early stages of what is expected to be a multi-quarter to multi-year (and sometimes disruptive) turnaround.
Looking forward, five categories of unaddressed PFAS liabilities remain, which could present a multi-billion-dollar risk to the company, adds the analyst.
The analyst raised adjusted EPS estimates to $7.25 (from $7.20) for FY24 and $7.90 (from $7.80) for FY25.
Investors can gain exposure to the stock via&nbsp;ProShares Smart Materials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINT#NYSE">TINT</a>) and&nbsp;FT Vest DJIA Dogs 10 Target Income ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/DOGG#BATS">DOGG</a>).
Price Action: MMM shares are down 3.91% at $126.58 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41447996/us-stocks-remains-on-edge-ahead-of-flurry-of-earnings-from-lockheed-martin-gm-and-others-this-is-st" target="_blank" rel="noreferrer noopener">US Stocks Remains On Edge Ahead Of Flurry Of Earnings From Lockheed Martin, GM And Others: This Is Still A &#8216;Buy The Dip&#8217; Market, Says Expert</a></li>
</ul>

Analyst Color

Equities

Reiteration

DOGG

TINT

3M's Earnings Impress, Yet Analysts See Long Road Ahead With Cyclical Recovery And PFAS Risks

B of A Securities analyst Andrew Obin maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Buy and raises the price target from $143 to $160.

B of A Securities Maintains Buy on 3M, Raises Price Target to $160

In the preceding three months, 12 analysts have released ratings for 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $143.92, along with a high estimate of $180.00 and a low estimate of $95.00. This upward trend is evident, with the current average reflecting a 19.6% increase from the previous average price target of $120.33.
<img src="https://www.benzinga.com/files/images/story/2024/1729695611_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive 3M. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Scott Davis</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$180.00</td>
<td>-</td>
</tr>
<tr>
<td>Brett Linzey</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Joe O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$140.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$125.00</td>
<td>-</td>
</tr>
<tr>
<td>Nicole Deblase</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>John Eade</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$145.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$133.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$143.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$95.00</td>
<td>$93.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 3M. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of 3M compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of 3M's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into 3M's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MMM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 3M analyst ratings.</a>
<h2>Delving into 3M's Background</h2>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>Key Indicators: 3M's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Challenges: 3M's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.45%. This indicates a decrease in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: 3M's net margin excels beyond industry benchmarks, reaching 18.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): 3M's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 26.08%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): 3M's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.32%, the company showcases efficient use of assets and strong financial health.
Debt Management: 3M's debt-to-equity ratio surpasses industry norms, standing at 3.5. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Landscape: 12 Takes On 3M

Barclays analyst Julian Mitchell maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Overweight and raises the price target from $160 to $165.

Barclays Maintains Overweight on 3M, Raises Price Target to $165

Throughout the last three months, 11 analysts have evaluated 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $142.0, a high estimate of $180.00, and a low estimate of $95.00. Marking an increase of 23.07%, the current average surpasses the previous average price target of $115.38. 
<img src="https://www.benzinga.com/files/images/story/2024/1729623636_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive 3M. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Davis</td>
<td>Melius Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$180.00</td>
<td>-</td>
</tr>
<tr>
<td>Brett Linzey</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Joe O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$140.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Underweight</td>
<td>$125.00</td>
<td>-</td>
</tr>
<tr>
<td>Nicole Deblase</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>John Eade</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$145.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$133.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$143.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$95.00</td>
<td>$93.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 3M. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of 3M compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of 3M's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into 3M's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MMM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on 3M analyst ratings.</a>
<h2>About 3M</h2>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
<h3>3M's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Negative Revenue Trend: Examining 3M's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -0.45% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: 3M's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.31%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): 3M's ROE excels beyond industry benchmarks, reaching 26.08%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): 3M's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.32%, the company showcases efficient use of assets and strong financial health.
Debt Management: 3M's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.5, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For 3M

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JOBY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$6.00</td>
<td>$42.3K</td>
<td>2.2K</td>
<td>11.4K</td>
</tr>
<tr>
<td>GRAB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$4.50</td>
<td>$37.5K</td>
<td>450</td>
<td>5.5K</td>
</tr>
<tr>
<td>ACHR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.50</td>
<td>$75.2K</td>
<td>49.2K</td>
<td>2.6K</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$140.00</td>
<td>$98.0K</td>
<td>290</td>
<td>1.4K</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/01/24</td>
<td>$160.00</td>
<td>$305.6K</td>
<td>377</td>
<td>973</td>
</tr>
<tr>
<td>LYFT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$15.00</td>
<td>$46.8K</td>
<td>320</td>
<td>274</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$24.00</td>
<td>$43.2K</td>
<td>1.0K</td>
<td>234</td>
</tr>
<tr>
<td>MYRG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$120.00</td>
<td>$106.8K</td>
<td>0</td>
<td>120</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/01/24</td>
<td>$287.50</td>
<td>$38.3K</td>
<td>164</td>
<td>59</td>
</tr>
<tr>
<td>UPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$130.00</td>
<td>$44.4K</td>
<td>1.1K</td>
<td>31</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For JOBY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>), we notice a call option sweep that happens to be bullish, expiring in 3 day(s) on October 25, 2024. This event was a transfer of 1058 contract(s) at a $6.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $42.3K, with a price of $40.0 per contract. There were 2214 open contracts at this strike prior to today, and today 11406 contract(s) were bought and sold. 
• Regarding GRAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>), we observe a call option sweep with bearish sentiment. It expires in 59 day(s) on December 20, 2024. Parties traded 2500 contract(s) at a $4.50 strike. This particular call needed to be split into 26 different trades to become filled. The total cost received by the writing party (or parties) was $37.5K, with a price of $15.0 per contract. There were 450 open contracts at this strike prior to today, and today 5532 contract(s) were bought and sold. 
• For ACHR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>), we notice a call option sweep that happens to be bearish, expiring in 87 day(s) on January 17, 2025. This event was a transfer of 2500 contract(s) at a $3.50 strike. This particular call needed to be split into 36 different trades to become filled. The total cost received by the writing party (or parties) was $75.2K, with a price of $30.0 per contract. There were 49222 open contracts at this strike prior to today, and today 2675 contract(s) were bought and sold. 
• For MMM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), we notice a put option sweep that happens to be bullish, expiring in 87 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $140.00 strike. This particular put needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $98.0K, with a price of $987.0 per contract. There were 290 open contracts at this strike prior to today, and today 1486 contract(s) were bought and sold. 
• For BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we notice a put option sweep that happens to be neutral, expiring in 10 day(s) on November 1, 2024. This event was a transfer of 597 contract(s) at a $160.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $305.6K, with a price of $512.0 per contract. There were 377 open contracts at this strike prior to today, and today 973 contract(s) were bought and sold. 
• Regarding LYFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>), we observe a put option sweep with bearish sentiment. It expires in 24 day(s) on November 15, 2024. Parties traded 242 contract(s) at a $15.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $46.8K, with a price of $194.0 per contract. There were 320 open contracts at this strike prior to today, and today 274 contract(s) were bought and sold. 
• For ZIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>), we notice a call option trade that happens to be bullish, expiring in 24 day(s) on November 15, 2024. This event was a transfer of 200 contract(s) at a $24.00 strike. The total cost received by the writing party (or parties) was $43.2K, with a price of $216.0 per contract. There were 1001 open contracts at this strike prior to today, and today 234 contract(s) were bought and sold. 
• Regarding MYRG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYRG#NASDAQ">MYRG</a>), we observe a put option trade with bullish sentiment. It expires in 59 day(s) on December 20, 2024. Parties traded 120 contract(s) at a $120.00 strike. The total cost received by the writing party (or parties) was $106.8K, with a price of $890.0 per contract. There were 0 open contracts at this strike prior to today, and today 120 contract(s) were bought and sold. 
• Regarding GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we observe a call option sweep with bearish sentiment. It expires in 10 day(s) on November 1, 2024. Parties traded 59 contract(s) at a $287.50 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $38.3K, with a price of $650.0 per contract. There were 164 open contracts at this strike prior to today, and today 59 contract(s) were bought and sold. 
• Regarding UPS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), we observe a put option trade with bearish sentiment. It expires in 451 day(s) on January 16, 2026. Parties traded 30 contract(s) at a $130.00 strike. The total cost received by the writing party (or parties) was $44.4K, with a price of $1480.0 per contract. There were 1101 open contracts at this strike prior to today, and today 31 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHR

GRAB

JOBY

LYFT

MYRG

10 Industrials Stocks With Whale Alerts In Today's Session

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election <a href="https://www.benzinga.com/topic/2024-elections">just two weeks away. </a>
Concerns over U.S. fiscal policies and potential shifts in economic direction fueled the pause in risk-taking.
The International Monetary Fund (IMF) upgraded its U.S. growth forecasts for 2024 and 2025 in the latest World Economic Outlook, while also flagging rising concerns about the country's debt trajectory, warning that with current large fiscal deficits, &#8220;the U.S. public debt is not stabilized.&#8221;
Commodities were the standout performers on Tuesday, with both metals and energy experiencing notable gains.
Gold, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), rose 0.8%, pushing further into record territory. This increase extended its year-to-date performance to 34%, positioning gold for its strongest <a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">annual gain since 1979.</a> Gold miners, as represented by the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), rallied for the ninth consecutive session, hitting their highest levels in over four years.
Silver, tracked by the iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>), surged 2.8%, reaching levels not seen since October 2012.
Oil prices rallied nearly 3%, building on a 2% surge from Monday. U.S. Treasury yields ticked up modestly on Tuesday following Monday's spike, with the 10-year yield settling at 4.21%.
Meanwhile, the U.S. Dollar Index (DXY), tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), climbed past the 104 mark, continuing its steady ascent and eyeing a fourth consecutive week of gains.
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 0.5%, dipping to around $67,000 and marking its second consecutive day of declines.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In US Major Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %change</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,907.57</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,840.39</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,291.15</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,228.60</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.3% to $581.79.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $429.14.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.4% to $493.29.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% $221.04.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 0.6%. The Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Performers</h3>
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) surged 9%, on track for its strongest session in nearly a year, after reporting stronger-than-expected earnings and announcing an additional $5 billion share buyback program extending into next year.
Other stocks reacting to earnings include: 
<ul>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), up 1.5%</li>
<li>Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), down 6%</li>
<li>W.R. Berkley Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), down 4.6%</li>
<li>Zion Bancorp. N.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), up 6.8%</li>
<li>Wintrust Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>), up 1.6%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 8.8%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), down over 8%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 3%</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), down 4.4%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 0.4%</li>
<li>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), down 5.8%</li>
<li>Fiserv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), down 0.4%</li>
<li>Moodys Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) down 4.5%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), down 0.9%</li>
<li>Freeport-McMoran Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), up 1.4%</li>
<li>Kimberly-Clark Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down 4%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 5.7%</li>
</ul>
Large-cap companies reporting earnings after the close include Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41455013/how-us-elections-could-impact-us-dollar-goldman-sachs-expects-greenback-will-remain-stronger-for-lon">How US Elections Could Impact US Dollar: Goldman Sachs Expects Greenback Will Remain &#8216;Stronger For Longer&#8217;</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

New ETFs

Currency ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

Market Vectors ETF Trust Market Vectors Gold Miners

MANH

SCCO

PowerShares DB US Dollar Index Bullish Fund

WTFC

ZION

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.
The Dow traded down 0.09% to 42,891.94 while the NASDAQ slipped 0.28% to 18,488.16. The S&amp;P 500 also fell, dropping, 0.30% to 5,836.28.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41426981/top-4-consumer-stocks-that-may-dip-this-quarter">Top 4 Consumer Stocks That May Dip This Quarter</a>
Leading and Lagging Sectors Energy shares rose by 0.5% on Tuesday.
In trading on Monday, industrials shares fell by 1.1%.
Top Headline
3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) reported better-than-expected third-quarter adjusted EPS and sales and revised FY24 EPS guidance.
The company reported net sales of $6.294 billion, a slight increase of 0.4% year-over-year. Adjusted net sales totaled $6.068 billion, up 1.5% on year and marginally beating the consensus of $6.057 billion. Adjusted EPS was $1.98, up 18% Y/Y, beating the consensus of $1.90.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) shares shot up 20% to $74.21 after the company announced that it was granted FDA clearance for its 510(k) submission related to prior design changes made to the Zio AT device.</li>
<li>Shares of Mueller Industries, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) got a boost, surging 16% to $83.91 after the company reported better-than-expected third-quarter sales results.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) shares were also up, gaining 40% to $1.2787 after the company announced the FDA approved an accelerated pathway for ST-920 in Fabry disease. A BLA submission is expected in 2025.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) shares dropped 20% to $114.60 after the company reported mixed third-quarter financial results and cut its FY24 EPS below estimates.</li>
<li>Shares of Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) were down 11% to $71.71 after the company reported worse-than-expected third-quarter EPS and sales and cut its 2024 guidance.</li>
<li>Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) was down, falling 10% to $83.01 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 2.8% to $72.54 while gold traded up 0.5% at $2,753.70.
Silver traded up 2.4% to $34.900 on Tuesday, while copper rose 0.3% to $4.3745.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.21%, Germany's DAX fell 0.20% and France's CAC 40 fell 0.01%. Spain's IBEX 35 Index fell 0.07%, while London's FTSE 100 fell 0.14%.
Passenger car registrations in the European Union fell by 6.1% year-over-year to 809,163 units in September following a 18.3% decline in August.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 1.39%, Hong Kong's Hang Seng Index gaining 0.1%, China's Shanghai Composite Index gaining 0.54% and India's BSE Sensex falling 1.15%.
The annual inflation rate in Hong Kong fell to 2.2% in September from 2.5% in the prior month.
Economics
The composite manufacturing index in the US Fifth District came in at -14 for October compared to a reading of -21 in the prior month.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41453972/top-3-defensive-stocks-that-may-keep-you-up-at-night-this-month">Top 3 Defensive Stocks That May Keep You Up At Night This Month</a></li>
</ul>

Intraday Update

IRTC

LOGI

SGMO

Crude Oil Rises Sharply; 3M Posts Upbeat Earnings

Melius Research analyst Scott Davis upgrades 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) from Hold to Buy and announces $180 price target.

Melius Research Upgrades 3M to Buy, Announces $180 Price Target

3M shares are trading lower after the company reported Q3 financial results. The stock initially traded higher, but it has since reversed.

Financial giants have made a conspicuous bullish move on 3M. Our analysis of options history for 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) revealed 17 unusual trades.
Delving into the details, we found 64% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $680,649, and 6 were calls, valued at $250,295.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $134.0 to $150.0 for 3M over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for 3M's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of 3M's whale activity within a strike price range from $134.0 to $150.0 in the last 30 days. 
<h3>3M Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729608353_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$13.6</td>
<td>$13.25</td>
<td>$13.32</td>
<td>$145.00</td>
<td>$94.6K</td>
<td style="text-align: right;">588</td>
<td style="text-align: right;">581</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$13.6</td>
<td>$13.2</td>
<td>$13.35</td>
<td>$145.00</td>
<td>$93.4K</td>
<td style="text-align: right;">588</td>
<td style="text-align: right;">651</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$20.75</td>
<td>$17.85</td>
<td>$18.88</td>
<td>$150.00</td>
<td>$84.9K</td>
<td style="text-align: right;">156</td>
<td style="text-align: right;">480</td>
</tr>
<tr>
<td>MMM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$17.9</td>
<td>$16.75</td>
<td>$16.87</td>
<td>$150.00</td>
<td>$76.0K</td>
<td style="text-align: right;">156</td>
<td style="text-align: right;">435</td>
</tr>
<tr>
<td>MMM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.55</td>
<td>$3.55</td>
<td>$3.55</td>
<td>$134.00</td>
<td>$59.9K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">172</td>
</tr>
</tbody>
</table>

<h3>About 3M</h3>
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
Having examined the options trading patterns of 3M, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of 3M</h3>
<ul>
<li>With a trading volume of 6,244,678, the price of MMM is down by -1.92%, reaching $132.25.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<h3>What The Experts Say On 3M</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $148.66666666666666.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on 3M with a target price of $146. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on 3M, maintaining a target price of $140. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on 3M with a target price of $160. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for 3M, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At 3M's Recent Unusual Options Activity

3M CEO Says Large Part Of Investment Going To Be In Safety & Industrial Business And Transportation & Electronics Business

Guidance

3M CO CEO Says In Q3 We Recovered $54M In Insurance Coverage Between Combat Arms And Public Water Suppliers; We Intend To Ramp Up Recovery Efforts And Expect Our Insurers To Honor Policy Obligations To US

Walt Disney, Cisco, And Shopify Headline Latest Earnings Week

Assessing MedTech impact from potential China tariffs

67 Aristocrats November Dividend Cornucopia Has 39 'Safer' And 2 Ideal Dogs

UBS last night upgraded 3M (MMM) to Buy from Neutral with a price target of $184, up from $130, after assuming coverage of the name. The analyst be...

3M assumed with Buy from Neutral at UBS

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Starbucks, Spotify downgraded: Wall Street's top analyst calls

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Charter (CHTR) agreed to acquire Liber...

Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz

Online shopping giant Amazon ($AMZN) has likely seen the same writing on the wall that a lot of other retailers have seen these days: people are re...

Amazon (NASDAQ:AMZN) Rolls Out Discount Store

How To Invest $100,000 In Large Cap Stocks: A Tax-Efficient Advisor-Less Strategy

3M (MMM) Receives a Hold from Wells Fargo

My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys

Comments

3M

뉴스

에 대한 최신 뉴스 3M (NYSE:MMM) 주식

화요일, 10월 22, 2024

금요일, 7월 26, 2024

일요일, 7월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌